Christine Mummery - Galapagos Non-Executive Independent Director
| GLPGF Stock | USD 26.20 9.32 26.24% |
Director
Dr. Christine Mummery, Ph.D. was NonExecutive Independent Director of Galapagos NV since November 4, 2015. As of 2008, Dr. Christine Mummery is Professor of Developmental Biology and Chair of the Department of Anatomy and Embryology at the Leiden University Medical Centre in The Netherlands. After her PhD in BioPhysics at London University, she was postdoctoral fellow at the Hubrecht Institute in Utrecht, later also staff member and group leader. She became Professor at the Interuniversity Cardiology of the Netherlands at the University Medical Centre Utrecht in 2002. In 2007, she was a joint Harvard Stem Cell InstituteRadcliffe fellow at Harvard and Massachusetts General Hospital at the time human induced pluripotent stem cells were being developed and was the first to derive iPSC lines from patients. Her primary research focus is currently the development and use of stem cells in cardiovascular development and disease. She served on the Ethical Councils of the Ministry of Health, is member of the Royal Netherlands Academy of Arts and Sciences, editor in chiefeditorial board member of several journals, former board member of ISSCR and pastpresident of the International Society of Differentiation. In addition, she chairs the executive board of the hDMT Institute for human Organ and Disease Model technologies, a nonprofit RD institute of which the LUMC is a founding partner. She is a review committee member of the European Research Council, the Leducq Foundation, the Wellcome Trust and the Heineken Jury Prize . since 2015.
| Age | 64 |
| Tenure | 9 years |
| Professional Marks | Ph.D |
| Phone | 32 1 534 29 00 |
| Web | https://www.glpg.com |
Galapagos Management Efficiency
The company has return on total asset (ROA) of (0.0119) % which means that it has lost $0.0119 on every $100 spent on assets. This is way below average. Galapagos' management efficiency ratios could be used to measure how well Galapagos manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Donald Oborowsky | Ceapro Inc | N/A | |
| Myrna Francis | Covalon Technologies | N/A | |
| Martin Bernholtz | Covalon Technologies | N/A | |
| Gale Pollock | Covalon Technologies | N/A | |
| Ronald Smith | Covalon Technologies | 66 | |
| William Li | Ceapro Inc | 49 | |
| Joseph Cordiano | Covalon Technologies | N/A | |
| John Hands | Covalon Technologies | N/A | |
| Glenn Rourke | Ceapro Inc | N/A | |
| John Suk | Covalon Technologies | N/A | |
| Ulrich Kosciessa | Ceapro Inc | N/A | |
| Elinor Caplan | Covalon Technologies | N/A | |
| Murray Miller | Covalon Technologies | N/A | |
| John Zupancic | Ceapro Inc | N/A | |
| Jeffrey Mandel | Covalon Technologies | N/A | |
| Ian Brindle | Covalon Technologies | N/A | |
Management Performance
| Return On Equity | 0.0021 | |||
| Return On Asset | -0.0119 |
Galapagos NV Leadership Team
Elected by the shareholders, the Galapagos' board of directors comprises two types of representatives: Galapagos inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Galapagos. The board's role is to monitor Galapagos' management team and ensure that shareholders' interests are well served. Galapagos' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Galapagos' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Rajesh Parekh, Non-Executive Chairman of the Board | ||
| Andre Hoekema, Sr. VP of Corporate Devel. | ||
| Katrine Bosley, Independent Non-Executive Director | ||
| John Montana, Managing Argenta | ||
| Walid AbiSaab, Member of the Executive Committee, Chief Medical Officer | ||
| Marieke Vermeersch, Head Communication | ||
| Howard Rowe, Non-Executive Independent Director | ||
| Bob Rajan, Non-Executive Independent Director | ||
| Harrold Barlingen, Non-Executive Director | ||
| Raj Parekh, Non-Executive Chairman of the Board | ||
| Elizabeth Goodwin, VP Corporate Communications & Investor Relations | ||
| Mary Kerr, Non-Executive Independent Director | ||
| Michele MBA, Chief Board | ||
| Piet Wigerinck, Chief Scientific Officer | ||
| Chantal Tasset, Head Devel | ||
| Sofie Gijsel, Head Relations | ||
| MBA MBA, COO Pres | ||
| Bart Filius, CFO | ||
| Christine Mummery, Non-Executive Independent Director | ||
| Werner Cautreels, Non-Executive Independent Director | ||
| Onno Stolpe, Co-Founder, CEO, Managing Director and Executive Director |
Galapagos Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Galapagos a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0021 | |||
| Return On Asset | -0.0119 | |||
| Profit Margin | 0.01 % | |||
| Operating Margin | (0.17) % | |||
| Current Valuation | (2.11 B) | |||
| Shares Outstanding | 65.84 M | |||
| Shares Owned By Insiders | 26.24 % | |||
| Shares Owned By Institutions | 32.13 % | |||
| Price To Earning | 454.11 X | |||
| Price To Book | 0.92 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Galapagos in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Galapagos' short interest history, or implied volatility extrapolated from Galapagos options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galapagos NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the Galapagos NV information on this page should be used as a complementary analysis to other Galapagos' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Complementary Tools for Galapagos Pink Sheet analysis
When running Galapagos' price analysis, check to measure Galapagos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galapagos is operating at the current time. Most of Galapagos' value examination focuses on studying past and present price action to predict the probability of Galapagos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galapagos' price. Additionally, you may evaluate how the addition of Galapagos to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |